These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 22926034)
41. Lipid-altering therapies and the progression of atherosclerotic disease. Wierzbicki AS Cardiovasc Intervent Radiol; 2007; 30(2):155-60. PubMed ID: 17206389 [TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease. Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease. Shah PK Eur Heart J; 2007 Jan; 28(1):5-12. PubMed ID: 17121756 [TBL] [Abstract][Full Text] [Related]
44. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Albert MA; Staggers J; Chew P; Ridker PM; Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301 [TBL] [Abstract][Full Text] [Related]
45. The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature. Diamantis E; Kyriakos G; Quiles-Sanchez LV; Farmaki P; Troupis T Curr Cardiol Rev; 2017; 13(3):209-216. PubMed ID: 28462692 [TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Bhatt DL Am J Cardiol; 2008 May; 101(10A):4D-13D. PubMed ID: 18474273 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic Role of Innovative Anti-Inflammatory Medications in the Prevention of Acute Coronary Syndrome. Pashun RA; Frishman WH Cardiol Rev; 2015; 23(5):252-60. PubMed ID: 25741604 [TBL] [Abstract][Full Text] [Related]
59. The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches. Tsioufis P; Theofilis P; Tsioufis K; Tousoulis D Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555579 [TBL] [Abstract][Full Text] [Related]
60. Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Ali M; Girgis S; Hassan A; Rudick S; Becker RC Coron Artery Dis; 2018 Aug; 29(5):429-437. PubMed ID: 29652673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]